PNC Financial Services Group
NMRA icon

PNC Financial Services Group’s Neumora Therapeutics NMRA Stock Holding History

PNC Financial Services Group’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7K Hold
1,000
– – ﹤0.01% 4724
2026
Q1 		$1.95K Hold
1,000
– – ﹤0.01% 4590
2025
Q4 		$1.79K Hold
1,000
– – ﹤0.01% 4554
2025
Q3 		$1.82K Hold
1,000
– – ﹤0.01% 4527
2025
Q2 		$733 Sell
1,000
-8,613
-90% -$6.53K ﹤0.01% 4616
2025
Q1 		$9.61K Buy
9,613
+3,613
+60% +$6.19K ﹤0.01% 3842
2024
Q4 		$63.6K Buy
+6,000
New +$71.9K ﹤0.01% 2958
2024
Q2 		– Sell
-5
Closed -$69 – 4870
2024
Q1 		$69 Buy
+5
New +$81 ﹤0.01% 4655

Other funds holding NMRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $5.44B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AH
Addis & Hill Wayne, Pennsylvania $181M AUM 21.74% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

PNC Financial Services Group's NMRA Position: Q2 2026 in Review

PNC Financial Services Group held its Neumora Therapeutics (NMRA) position steady in Q2 2026 at 1,000 shares worth $1.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4724.

PNC Financial Services Group first reported a position in NMRA in Q1 2024 and has held it in 8 quarters since. The position peaked at $63.6K in Q4 2024. 35 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • PNC Financial Services Group held 1,000 shares of Neumora Therapeutics worth $1.7K as of Q2 2026.
  • PNC Financial Services Group left its Neumora Therapeutics share count unchanged in Q2 2026.
  • Neumora Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4724 holding.
  • PNC Financial Services Group first reported a position in Neumora Therapeutics in Q1 2024 and has held it in 8 quarters since.
  • PNC Financial Services Group's Neumora Therapeutics position peaked at $63.6K in Q4 2024.
  • 35 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.